Cite
Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest
MLA
Daya, Mohamud R., et al. “Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest.” Circulation (Ovid), vol. 141, no. 3, Jan. 2020, pp. 188–98. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.119.042240.
APA
Daya, M. R., Leroux, B. G., Dorian, P., Rea, T. D., Newgard, C. D., Morrison, L. J., Lupton, J. R., Menegazzi, J. J., Ornato, J. P., Sopko, G., Christenson, J., Idris, A., Mody, P., Vilke, G. M., Herdeman, C., Barbic, D., & Kudenchuk, P. J. (2020). Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest. Circulation (Ovid), 141(3), 188–198. https://doi.org/10.1161/CIRCULATIONAHA.119.042240
Chicago
Daya, Mohamud R., Brian G. Leroux, Paul Dorian, Thomas D. Rea, Craig D. Newgard, Laurie J. Morrison, Joshua R. Lupton, et al. 2020. “Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest.” Circulation (Ovid) 141 (3): 188–98. doi:10.1161/CIRCULATIONAHA.119.042240.